PATENT CLAIM ANALYSIS

Application Number: 15893779
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-06
Patent Classification: ["514", "260100"]

Abstract:
The present invention provides for the design and synthesis of halogenated thieno- and pyrrolopyrimidine compounds that exhibit cancer proliferation inhibitory activity and the use thereof for cancer treatment.

Claim (Index 3):
A halogenated pyrrolopyrimidine compound having the following formula: wherein X is NH and Y is H or I.

Metadata:
- Claim Count in Document: 3.0
- Percentile: 88.0
- Lexical Diversity: 1.20833
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14634940', '15249980', '15453953', '14244445', '12072269']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.781763669758245
- 35 USC 102 Novelty (BERT): 0.5548877838048227
- Combined Prediction Score: 0.7590760811629027
- Mean Citation Score: 301.02433600000006
- Max Citation Score: 444.9711
- Similarity Product: 297.5866976659655

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test